PKC theta inhibitors (PharmaGap/MD Biosciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePKC theta inhibitors (PharmaGap/MD Biosciences)
Drug Alias NamePKC theta inhibitor (PharmaGap)protein kinase C theta inhibitor (PharmaGap)protein kinase theta inhibitors (PharmaGap/MD Biosciences)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtein kinase C theta inhibitors
TargetsProtein kinase C theta
Therapy Area/IndicationsInflammationNervous System DiseasesSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaGap Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaGap IncMD Biosciences GmbH
Active IndicationsN/A
Inactive IndicationsInflammationNervous System DiseasesSarcoma

Other Information

ATC CodeN/A
Related LinksN/A